Nectar Lifesciences is currently trading at Rs. 54.75, up by 0.85 points or 1.58% from its previous closing of Rs. 53.90 on the BSE.
The scrip opened at Rs. 54.15 and has touched a high and low of Rs. 54.75 and Rs. 54.15 respectively. So far 21187 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 60.90 on 08-Dec-2015 and a 52 week low of Rs. 27.00 on 27-Feb-2015.
Last one week high and low of the scrip stood at Rs. 56.15 and Rs. 52.30 respectively. The current market cap of the company is Rs. 1208.77 crore.
The promoters holding in the company stood at 44.35% while Institutions and Non-Institutions held 14.36% and 20.78% respectively.
Nectar Lifesciences, the fast-growing manufacturer of generic pharmaceutical active pharmaceutical ingredients (APIs) and formulation products, has been awarded the coveted National Energy Conservation Award - 2015 (NECA) organized by BEE (Bureau of Energy Efficiency, Ministry of Power, Government of India).
This National Energy Conservation Award programme promotes energy efficiency and the adoption of clean and innovative technologies in industrial and other sectors. The company has participated in the chemical sector of this National Level Competition and has won this award for the first time.
Nectar Lifesciences is a leading integrated pharmaceutical organization in India, offering a specialized comprehensive range of oral and sterile cephalosporin and Carbapenem active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |